Contact this trialFirst, we need to learn more about you.
Carbonic Anhydrase Inhibitor
Pressure-Lowering Eye Drops for Glaucoma
Recruiting4 awardsPhase 3
Miami, Florida
This trial will study whether a retinal ganglion cell function test can predict which glaucoma suspects will benefit from pressure-lowering eye drops.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.